Clinical Trial Results:
            A Randomized, Open Label, Multi-Center Phase 2 Study of nab-Paclitaxel versus Epigenetic Modifying Therapy of CC-486 with nab-Paclitaxel in Subjects with Chemotherapy Naïve Metastatic Melanoma
    
| 
                 Summary 
         | 
        |
    EudraCT number  | 
        2013-002291-41 | 
    Trial protocol  | 
        IT | 
    Global completion date  | 
        |
| 
                 Paediatric regulatory details 
         | 
        |
    Is the trial part of an agreed EMA paediatric investigation plan?  | 
        |
    Is the trial in scope of article 45 of Regulation (EC) No 1901/2006?  | 
        |
    Is the trial in scope of article 46 of Regulation (EC) No 1901/2006?  | 
        |
| 
                 Results information 
         | 
        |
    Results version number  | 
        v1(current) | 
    This version publication date  | 
        
                                    03 Oct 2021
                             
         | 
    
    First version publication date  | 
        
                                    03 Oct 2021
                             
         | 
    
    Other versions  | 
        |
    Summary report(s)  | 
                                2013-002291-41_CC-487-Mel-001 | 
    
            Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to            Commission Guideline 2012/C 302/03
            for further information.